BBSRC Portfolio Analyser
Award details
Untargeted metabolomics of serum samples during COVID-19 disease progression
Reference
BB/V003976/1
Principal Investigator / Supervisor
Professor Douglas Kell
Co-Investigators /
Co-Supervisors
Professor Royston Goodacre
Institution
University of Liverpool
Department
Biochemistry
Funding type
Research
Value (£)
171,100
Status
Completed
Type
Research Grant
Start date
28/05/2020
End date
27/05/2021
Duration
12 months
Abstract
unavailable
Summary
Understanding changes in the biochemistry of an individual who is ostensibly healthy, including when they may show no overt symptoms of infection with SARS-Cov2, remains a huge challenge. Similar questions apply to understanding who is likely to live (unaided or via intervention) and who will die from COVID-19 once diagnosed, and the answers are equally unknown. Since we do not presently have any knowledge (although we know that there are cardiovascular changes that should have easily measured metabolic consequences (Zheng YY, Ma YT, Zhang JY, Xie X: COVID-19 and the cardiovascular system. Nat Rev Cardiol 2020), the best approach is to measure everything and find out. This approach is known as 'untargeted metabolomics'. We are experts in it (Kell co-invented the term 'metabolome'), and have already discovered novel measures of cardiovascular stress. We now wish to apply these to cohorts of serum samples that are already being collected in Liverpool and which will be made available to us (after treatment to remove all proteins, including virus). We anticipate that we shall be able to find markers that could be very early predictors of COVID-19 infection and prognosis.
Committee
Not funded via Committee
Research Topics
Microbiology
Research Priority
X – Research Priority information not available
Research Initiative
Covid19 Rapid Response [2020]
Funding Scheme
X – not Funded via a specific Funding Scheme
I accept the
terms and conditions of use
(opens in new window)
export PDF file
back to list
new search